Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis

Area of Science:

• Immunogenetics
• Dermatology
• Molecular Biology

Background:

• Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine.
• Elevated MIF levels and overexpression in psoriatic plaques are observed in psoriasis patients.
• MIF gene promoter polymorphisms are linked to increased MIF production and susceptibility to inflammatory diseases.

Purpose of the Study:

• To investigate the association between MIF gene promoter polymorphisms and chronic plaque psoriasis susceptibility.
• To determine if specific MIF gene variants contribute to the risk of developing psoriasis.

Main Methods:

• Genotyping of MIF promoter polymorphisms (MIF-173*C and CATT(7)) in 228 UK Caucasian psoriasis patients and 401 controls.
• Analysis using allelic discrimination, fluorescently labeled primer method, and capillary gel electrophoresis.
• Statistical analysis of genotype and haplotype frequencies to assess correlation with psoriasis.

Main Results:

• Carriage of the MIF-173*C polymorphism showed a positive correlation with psoriasis (OR 1.52, p=0.024).
• Carriage of the MIF CATT(7) polymorphism was also positively correlated with psoriasis (OR 1.67, p=0.013).
• The CATT(7)-MIF-173(*)C haplotype demonstrated a significant association with psoriasis susceptibility (OR 1.69, p=0.008).

Conclusions:

• Polymorphisms in the MIF gene are important factors in psoriasis susceptibility.
• The CATT(7)-MIF-173(*)C haplotype specifically confers increased risk for developing chronic plaque psoriasis.
• These findings highlight the role of MIF gene variations in the pathogenesis of psoriasis.